Introduction Type 1 hepatorenal syndrome (HRS-1) is a rapidly progressing kidney failure that occurs in patients with decompensated cirrhosis and ascites. Left untreated, HRS-1 is often fatal, with a median survival of weeks to months. Pharmacotherapy with vasopressors, such as terlipressin, has shown potential in reversing hemodynamic abnormalities associated with advanced cirrhosis and improving renal…